| Index | — | P/E | 22.06 | EPS (ttm) | 5.70 | Insider Own | 6.67% | Shs Outstand | 18.67M | Perf Week | 3.78% |
| Market Cap | 2.35B | Forward P/E | 16.68 | EPS next Y | 7.54 | Insider Trans | -0.06% | Shs Float | 18.13M | Perf Month | 13.01% |
| Enterprise Value | 2.34B | PEG | 3.35 | EPS next Q | 1.79 | Short Float | 4.27% | Perf Quarter | 10.64% | ||
| Income | 106.00M | P/S | 1.59 | EPS this Y | 13.78% | Short Ratio | 3.66 | Perf Half Y | 25.60% | ||
| Sales | 1.48B | P/B | 2.05 | EPS next Y | 7.01% | ROA | 7.23% | Short Interest | 774.00K | Perf YTD | 17.10% |
| Book/sh | 61.47 | P/C | 23.48 | EPS next 5Y | 6.59% | ROE | 9.57% | 52W High | 127.06 -1.03% | Perf Year | 6.63% |
| Cash/sh | 5.36 | P/FCF | 15.35 | EPS past 3/5Y | 22.42% 20.16% | ROIC | 8.52% | 52W Low | 87.95 42.98% | Perf 3Y | 54.66% |
| Dividend Est. | — | EV/EBITDA | 13.95 | Sales past 3/5Y | 14.38% 13.22% | Gross Margin | 32.36% | Volatility | 2.23% 2.31% | Perf 5Y | 53.35% |
| Dividend TTM | — | EV/Sales | 1.59 | EPS Y/Y TTM | 25.83% | Oper. Margin | 10.04% | ATR (14) | 2.85 | Perf 10Y | 374.89% |
| Dividend Ex-Date | — | Quick Ratio | 1.69 | Sales Y/Y TTM | 15.86% | Profit Margin | 7.13% | RSI (14) | 73.47 | Recom | 2.25 |
| Dividend Gr. 3/5Y | — | Current Ratio | 1.69 | EPS Q/Q | 16.11% | SMA20 | 6.12% | Beta | 0.73 | Target Price | 122.33 |
| Payout | 0.00% | Debt/Eq | 0.08 | Sales Q/Q | 8.02% | SMA50 | 7.38% | Rel Volume | 2.43 | Prev Close | 125.54 |
| Employees | 50,659 | LT Debt/Eq | 0.08 | Earnings | Nov 03 | SMA200 | 18.15% | Avg Volume | 209.19K | Price | 125.75 |
| IPO Date | Oct 28, 2009 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 1.88% 0.31% | Net Debt/EBITDA | -0.02 | Volume | 508,389 | Change | 0.17% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-28-26 | Reiterated | Raymond James | Outperform | $125 → $137 |
| Sep-14-26 | Reiterated | Raymond James | Outperform | $125 |
| Sep-14-26 | Downgrade | B of A Securities | Buy → Neutral | |
| Aug-05-26 | Reiterated | RBC Capital | Outperform | $139 → $134 |
| May-15-26 | Reiterated | Barclays | Underweight | $112 → $92 |
| Feb-25-26 | Reiterated | RBC Capital | Outperform | $141 → $139 |
| Feb-24-26 | Reiterated | Barclays | Underweight | $117 → $112 |
| Jan-07-26 | Initiated | Truist | Buy | $135 |
| Nov-04-25 | Reiterated | Barclays | Underweight | $83 → $117 |
| Sep-02-25 | Initiated | UBS | Buy | $145 |
Addus HomeCare Corporation, through its various subsidiaries, offers essential personal support services across the United States. The company primarily assists seniors, individuals with chronic illnesses or disabilities, and those at risk of hospitalization or institutionalization. Its operations are structured into three primary segments: Personal Care, Hospice, and Home Health. The Personal Care division delivers non-medical assistance with daily living activities, including help with personal hygiene (bathing, grooming, oral care), eating, dressing, medication reminders, meal preparation, household chores, and transportation. Through its Hospice segment, Addus provides compassionate palliative nursing care, social work, spiritual guidance, homemaker services, and bereavement support to terminally ill individuals and their families. The Home Health segment delivers professional skilled nursing care alongside physical, occupational, and speech therapy for patients recovering from illness or following a hospital discharge. Addus HomeCare's diverse client base includes federal, state, and local government entities, managed care organizations, commercial insurance providers, and private-paying individuals. As of December 31, 2021, the company served consumers through a network of 206 offices located across 22 states. Established in 1979, Addus HomeCare Corporation is headquartered in Frisco, Texas.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,476 | 1,423 | 1,155 | 1,059 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 999 | 961 | 780 | 719 | — | — | — | — | — | |
| Gross Profit | 479 | 462 | 375 | 340 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 312 | 307 | 259 | 232 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 18 | 16 | 13 | 17 | — | — | — | — | — | |
| Operating Income | 148 | 139 | 103 | 91 | — | — | — | — | — | |
| Interest Expense | 10 | 10 | 8 | 11 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 4 | -2 | 4 | 1 | — | — | — | — | — | |
| Net Income Before Taxes | 140 | 127 | 99 | 81 | — | — | — | — | — | |
| Income Taxes | 35 | 32 | 26 | 19 | — | — | — | — | — | |
| Consolidated Net Income | 106 | 96 | 74 | 63 | — | — | — | — | — | |
| Net Income From Continuing Operations | 106 | 96 | 74 | 63 | — | — | — | — | — | |
| Net Income | 106 | 96 | 74 | 63 | — | — | — | — | — | |
| EPS (Recurring) | 5.68 | 5.19 | 4.33 | 3.91 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 5.68 | 5.19 | 4.33 | 3.91 | — | — | — | — | — | |
| EPS (Diluted) | 5.70 | 5.21 | 4.23 | 3.83 | — | — | — | — | — | |
| EBITDA | 168 | 153 | 121 | 107 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 22.06 | 20.61 | 29.63 | 24.24 | — | — | — | — | — | |
| Price To Sales Ratio | 1.53 | 1.36 | 1.84 | 1.40 | — | — | — | — | — | |
| Gross Margin | 32.45 | 32.47 | 32.47 | 32.11 | — | — | — | — | — | |
| Operating Margin | 10.03 | 9.77 | 8.92 | 8.59 | — | — | — | — | — | |
| Net Margin | 7.18 | 6.75 | 6.41 | 5.95 | — | — | — | — | — | |
| Shares Outstanding | 18 | 18 | 17 | 16 | — | — | — | — | — | |
| Market Capitalization | 2,264 | 1,933 | 2,131 | 1,486 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Dixon Heather Brianne | President and Chief Operating | Jun 22 '26 | Sale | 93.77 | 288 | 27,006 | 44,371 | Jun 23 |
| Lopez Esteban | Director | May 21 '26 | Sale | 93.00 | 250 | 23,250 | 3,200 | May 22 |
| Lopez Esteban | Director | May 19 '26 | Sale | 93.00 | 250 | 23,250 | 3,450 | May 21 |
| BLESSING CLIFF DONALD | EVP, Chief Development Officer | Apr 21 '26 | Sale | 93.61 | 178 | 16,663 | 12,183 | Apr 22 |
| RAINES MONICA | EVP, CCO and Quality Officer | Mar 02 '26 | Sale | 102.15 | 224 | 22,882 | 13,577 | Mar 03 |
| WATTENBARGER MICHAEL D. | EVP, Chief Information Officer | Feb 25 '26 | Sale | 105.36 | 300 | 31,608 | 9,444 | Feb 26 |
| RAINES MONICA | EVP, CCO and Quality Officer | Feb 25 '26 | Sale | 105.36 | 219 | 23,074 | 13,801 | Feb 26 |
| Stevenson Roberton James | EVP, Chief HR Officer | Feb 25 '26 | Sale | 105.36 | 284 | 29,922 | 14,030 | Feb 26 |
| BLESSING CLIFF DONALD | EVP, Chief Development Officer | Feb 25 '26 | Sale | 105.36 | 177 | 18,649 | 12,361 | Feb 26 |
| ALLISON R DIRK | Chairman and CEO | Feb 25 '26 | Sale | 105.36 | 2,364 | 249,071 | 183,150 | Feb 26 |
| POFF BRIAN | EVP, Chief Financial Officer | Feb 25 '26 | Sale | 105.36 | 820 | 86,395 | 63,692 | Feb 26 |
| TUCKER DAVID W. | EVP, Chief Strategy Officer | Feb 25 '26 | Sale | 105.36 | 379 | 39,931 | 10,423 | Feb 26 |
| Anderson Darby | EVP, Chief Govt Rel Officer | Feb 25 '26 | Sale | 105.36 | 396 | 41,723 | 46,246 | Feb 26 |
| GAFFNEY SEAN | EVP, Chief Legal Officer | Feb 25 '26 | Sale | 105.36 | 442 | 46,569 | 20,080 | Feb 26 |
| POFF BRIAN | EVP, Chief Financial Officer | Feb 24 '26 | Sale | 106.98 | 2,041 | 218,346 | 64,512 | Feb 26 |